Taiji Yamashita Selected Research

Taiji Yamashita Research Topics

4	Atherosclerosis 10/2013 - 09/2011
4	Hyperlipidemias (Hyperlipidemia) 01/2012 - 01/2011
3	Cardiovascular Diseases (Cardiovascular Disease) 08/2014 - 09/2011
2	Obesity 08/2014 - 08/2014
2	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2012 - 01/2010
2	Coronary Artery Disease (Coronary Atherosclerosis) 01/2012 - 01/2010
1	Body Weight (Weight, Body) 08/2014
1	Inflammation (Inflammations) 10/2013
1	Heart Failure 01/2013
1	Fibrosis (Cirrhosis) 01/2013
1	Cardiomyopathies (Cardiomyopathy) 01/2013
1	Myocardial Infarction 01/2013
1	Insulin Resistance 12/2012
1	Platelet Glycoprotein IV Deficiency 01/2012
1	Muscle Weakness 01/2012
1	Coronary Disease (Coronary Heart Disease) 09/2011
1	Headache (Headaches) 10/2010
1	Fever (Fevers) 10/2010
1	Type 2 Diabetes Mellitus (MODY) 01/2010

4	AdiponectinIBA 08/2014 - 01/2010
4	Lipoproteins (Lipoprotein)IBA 12/2012 - 01/2011
4	Apolipoprotein B-48IBA 01/2012 - 01/2011
3	Triglycerides (Triacylglycerol)IBA 01/2012 - 01/2011
2	LeptinIBA 08/2014 - 08/2014
2	oxidized low density lipoproteinIBA 12/2012 - 01/2012
2	SteroidsIBA 01/2012 - 10/2010
1	Brain Natriuretic Peptide (Natrecor)FDA Link 08/2014
1	ProgranulinsIBA 10/2013
1	Apolipoproteins E (ApoE)IBA 10/2013
1	Proteins (Proteins, Gene)FDA Link 10/2013
1	Tissue Inhibitor of Metalloproteinase-1IBA 01/2013
1	Messenger RNA (mRNA)IBA 01/2013
1	CholesterolIBA 12/2012
1	Hypolipidemic Agents (Antihyperlipidemics)IBA 01/2012
1	Cyclosporine (Ciclosporin)FDA LinkGeneric 01/2012
1	CD36 AntigensIBA 01/2012
1	ChylomicronsIBA 09/2011
1	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 10/2010

1	Ligation 01/2013
1	Glycemic Control 01/2010